It is well known that aberrant activation of MAP kinase pathways induced by activating mutations in KRAS or BRAF contributes to abnormal cell growth and functions as a critical mechanism leading to tumorigenesis of colon cancer. This evidence concerns the gene KRAS and malignant colon neoplasm.